Doxorubicin Market Demand, Growth Potential and Opportunity Outlook 2028

1
Doxorubicin Market 
Doxorubicin Market Forecast to 2028 - COVID-19
Impact and Global Analysis By Drug Formulation
(Lyophilized Powder and Doxorubicin Injection),
Application (Breast Cancer, Kidney Cancer, Liver
Cancer, Sarcoma, Ovarian Cancer, Lung Cancer,
Leukemia, Multiple Myeloma, and Others), and
Distribution Channel (Hospital Pharmacy, Retail
Pharmacy, and Online Pharmacy)
2
Current and future Market Scenario
Doxorubicin Market 
According to our latest study, titled
Doxorubicin Market Forecast to 2028 COVID-19
Impact and Global Analysis By Drug Formulation,
Distribution Channel, and Geography," the market
is expected to reach US 1,983.40 million in 2028
from US 1,390.64 million in 2022. It is
estimated to grow at a CAGR of 6.1 during
20222028. The report highlights the key factors
driving the doxorubicin market growth and
prominent players with their developments in the
global doxorubicin market. Key factors driving
the market's growth are the increasing prevalence
of cancer and the increasing preference for
chemotherapy. However, the potential side effects
associated with doxorubicin are expected to
restrict the market growth during the forecast
period. The market for doxorubicin before the
pandemic was constantly growing as regular cancer
screening, consultations, and treatments were
going on. The market was highly affected due to
the outbreak of Covid-19. The first wave of
COVID-19 disrupted the consultations, follow-ups,
screenings, and oncological cases' treatments. As
a result, health care systems were overburdened,
and the delivery of medical care to all patients
became a challenge in the region. In addition,
most pharmaceutical and medical device companies
and research institutes were engaged in
developing COVID-19 vaccines and related
products. The chaotic situation was created in
the healthcare industry across the countries,
leading to a reduced number of consultations and
a smaller number of cancer cases diagnosed. For
instance, international efforts suggest that the
diagnoses of cancers were reduced by 40 between
March 9 and May 17, 2020, compared to diagnoses
averaged over the same period in 2018 and 2019.
In its disruption of clinical trials and drug
supply to patients, the COVID-19 pandemic has
impacted the most crucial areas of the global
doxorubicin market.
3
Market Segments
Doxorubicin Market   
Application Breast Cancer Kidney Cancer Liver
Cancer Sarcoma Ovarian Cancer Others
Drug Formulation Lyophilized Powder Doxorubicin
Injection
By Geography North America Europe Asia Pacific
(APAC) Middle East and Africa (MEA) South America
4
Leading Players
Doxorubicin Market  
Company Profiles in Doxorubicin Market
are Accord Healthcare Cipla Inc. Dr. Reddy's
Laboratories Meiji Holdings Co., Ltd. Janssen
Pharmaceuticals (Johnson and Johnson Services,
Inc.) Novartis AG Pfizer Inc. Sun Pharmaceutical
Industries Ltd Baxter International Inc. Zydus
Cadila
5
Doxorubicin Market  
Access Full Research Report at
https//www.theinsightpartners.com/reports/doxorub
icin-market
Thank You!

• Thank You!